TGFB1 and head and neck squamous cell carcinoma: Here, we report what to our knowledge is the first study to describe the clinical results and tissue correlative analyses of neoadjuvant PD-L1 and TGF-β blockade in patients with newly diagnosed HPV-unrelated HNSCC.